Off-patent Drugs Bill

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

The Off-patent Drugs Bill is a Bill introduced before the Parliament of the United Kingdom by Jonathan Evans in October 2014. It aims to make the British government seek new licences for off-patent medicines that could benefit patients whenever pharmaceutical companies fail to do so because there is no financial incentive.[1] The bill's second reading order lapsed in December 2014.[2] As a private member's bill (from an MP standing down in the 2015 General Election[1]) it is unlikely to progress further. Passage of legislation on off-patent drugs has been supported by charities such as Breast Cancer Now. An Off-patent Drugs Bill was introduced as a PMB in the 2015 Parliament by Nick Thomas-Symonds MP.[3]

References[edit]

  1. ^ a b Cooper, Charlie (6 November 2014). "Lives will be lost unless the Government acts on off-patent drugs, charities warn". The Independent. Retrieved 14 January 2015.
  2. ^ "Off-patent Drugs Bill 2014-15". Parliament. Retrieved 14 January 2015.
  3. ^ https://twitter.com/NickTorfaenMP/status/613685242243739649